͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | We have partnered with the American Cancer Society to jointly consider applications for our Biology to Prevention Award.
The partnership doubles the pot of funding available through the award, now up to the equivalent of £1.2m per grant, to support transatlantic research teams taking a multi-disciplinary approach to critical research questions in primary prevention.
The funding round is open and accepting research proposals until 19 June. Visit the Award page for information about remit and how to apply.
Sign up for our webinar on 21 May at 16:00 BST / 11:00 EDT / 08:00 PDT to discover everything you need to know to apply for co-funding through the Biology to Prevention Award scheme. |
| | |
|
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | | | | | | | | | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
| | Mapping improvements for teenagers and young adults with cancer |
| An ECMC road map is set to play a key role in improving clinical trial access for teenagers and young adults (TYA) with cancer — a group that faces unique challenges and has limited opportunities to participate in trials.
Gillian Horne, from the University of Glasgow, spoke with us about why the roadmap is so important. She draws on her clinical interest in teenage and young adult cancer care and her work with the ECMC North TYA working group and describes the road map as an invaluable tool that can help close the gap in trial access. |
| | |
|
|
|
|
|
 | | | | Are you curious about starting your entrepreneurial journey? Don’t miss this chance to gain honest, unfiltered insights from other women who have made the leap from lab to launch, expand your network of collaborators and meet industry professionals and investors.
Lab2Launch: Empowering Women to Build Businesses from Breakthroughs is a half-day event that will take place on 13 May at the Francis Crick Institute.
You can expect insights from keynote speakers including Lesley Regan (Women’s Health Ambassador for England), inspiring stories from women academics-turned-founders and great networking opportunities. | | |
| |  | | | | The early bird registration deadline for the Cancer Prevention Research Conference 2025 is fast approaching, with the last few discounted tickets only available until Friday 9 May.
Register to join us for keynotes from Allan Balmain, John Burn and Elisabete Weiderpass, insights on prevention implementation from Linda Bauld, Susan Domchek, Susan Jebb and Richard Sullivan, debates about the hotly contested GLP1 agonists with Andrew Renehan and Michael Pollak and much more from 25–27 June.
Don't miss this unique opportunity to hear the latest developments in cancer prevention and connect with researchers from all around the world – at a discounted ticket rate. | | |
|
|---|
|
|
|
|
Latest in data from Cancer News |
|
|
|
|
 | | | | Our data community leads are developing and testing solutions to data challenges, equipping researchers with the tools they need to maximise data use and accelerate life-saving discoveries.
Mieke Van Hemelrijck (King’s College London) will create a seamless infrastructure where researchers can efficiently integrate and analyse data without compromising security or patient confidentiality.
Frances Pearl (University of Sussex) is making datasets easier to find, access and reuse by building an online data hub where researchers can search for available cancer datasets funded by us.
Harriet Unsworth (Cancer Research UK National Biomarker Centre) is joining the Data Science for Health Equity to co-develop solutions to address the lack of diversity in healthcare and biomedical datasets. | | |
| |  | | | | Whilst big data holds wide-reaching potential for cancer research, challenges around data sharing mean this opportunity remains untapped.
Gemma Codner, our Data Community Coordinator, shares her take on the steps needed to overcome the challenges in unlocking the full potential of big data in cancer research.
Our data community is one way we’re adapting to a rapidly evolving data landscape. Gemma oversees six special interest groups focusing on critical challenges in cancer data research, identifying barriers to data access and sample reuse and exploring solutions to drive advancements in cancer research. | | |
|
|---|
|
|
|
|
| | #CRUKFunded: A human model to deconvolve genotype-phenotype causations in lung squamous cell carcinoma |
| A team led by Carlos Lopez-Garcia at our Manchester Institute, with funding from NC3Rs and our Lung Cancer Centre of Excellence, has developed a novel human model of lung squamous cell carcinoma (LUSC) using genetically engineered human bronchial epithelial cells — the cells that give rise to LUSC.
This new in vitro model integrates the dysregulation of the most commonly altered pathways in LUSC and offers a more cost-effective, versatile and scalable alternative to mouse models.
This approach can be applied to study various LUSC subtypes, identify new vulnerabilities and serve as a platform for preclinical research. |
| | |
|
|
|
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
